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Abstract
OBJECTIVE: To study the effects of berberine on ac-
tivity and mRNA expression of N-acetyltransferase
in human lung cancer cell line A549.
METHODS: N-acetyltransferase antibodies were
prepared. The human lung cancer A549 cells were
cultivated randomly in the wells of culture plate,
and divided into the control group, and berberine
0.0008, 0.008, 0.08, 0.8 and 1.6 mM treatment
groups, with 3 wells for each group. 24 h later, A549
cells in each group were collected respectively, the
content of N-acetyltransferase was detected by
Flow cytometry, and the mRNA expression of
N-acetyltransferase was observed by reverse tran-
scription polymerase chain reaction.
RESULTS: The N-acetyltransferase content in hu-
man lung cancer A549 cells decreased with the in-
creasing of berberine concentration, significantly
lower than that in the control group (P<0.05 or P<
0.001); and the mRNA expression of N-acetyltrans-
ferase also decreased with the increasing of berber-
ine concentration, significantly lower in Huanglian-
su treatment groups (P<0.001).
CONCLUSION: Berberine can inhibit the activity of
N-acetyltransferase in human lung cancer cell line
A549, and shows negative correlations of dose and
time in a certain extent. The inhibited gene expres-
sion of N-acetyltransferase in human lung cancer
A549 cell may probably represent one of the mech-
anisms for its antineoplastic effect.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Malignant tumor is one kind of pathological state of
abnormal hyperplasia of the cells. According to the sta-
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tistics from Ministry of Health of China, malignant tu-
mor has become the first factor in ten major death
causes. Among them, mortality of lung cancer is the
highest than that of the other cancers. The cancer-in-
ducing factors predominantly come from the environ-
mental agents, and about 80% cancers are caused by
chemical carcinogens. Many chemical materials exist
with stable structures in nature, and exposure in envi-
ronmental chemical carcinogens is not sure to cause
damage to the cell; but if catalyzed to active carcino-
gens by endosomatic enzyme, they may be combined
with DNA to form DNA adduct, and induce gene mu-
tation to generate cancer. N-acetyltransferase (NAT) is
just one of the enzymes involved in catalyzing carcino-
gens.1 Some research papers pointed out that NAT was
related to the carcinogenicity of arylamine compound,
if the NAT activity in human body increased, mean-
while, getting in touch with arylamine compound, the
probability of cancer occurrence would increase.2
Therefore, if the NAT activity can be decreased, and
carcinogens have no way to be acetylated when they
get into the body, the formation of DNA adduct
may be reduced and unlikely cause mutation to fo-
ment cancer.
Berberine, also called Umbellatine, is an alkaloid ex-
tracted originally in large amount from the common-
ly-used Chinese herb Huanglian (Rhizoma Coptidis);
and this component is also contained in Huangbai
(Cortex Phellodendri Amurensis). It is pointed out in
Ben Cao Bei Yao3 that Huanglian (Rhizoma Coptidis) is
extremely bitter and cold, and can purge fire and cool
blood, and can purge lung-fire if used in combination
with Huangqin (Radix Scutellariae Baicalensis), so it be-
longs to the heat-clearing and toxin-resolving medici-
nal herb. The early researches about berberine mostly
lie in antagonizing microorganism; afterwards, except
the antisepticise, berberine has many other effects to be
confirmed, such as anti-inflammation, reducing blood
sugar, lowering blood pressure, antagonizing arrhyth-
mia, protecting the liver, and so on.4 It also has an anti-
cancer effect, the mechanism lies in inhibiting the inva-
sion and metastasis of cancer cells and reducing their
proliferation induced by spontaneous and environmen-
tal stimulus.5 At present, the research papers show that
berberine can inhibit many kinds of cancer cells, such
as human leukemia cells, esophageal cancer cells, carci-
noma cells of the large intestine, and so on.6-10 But,
there are no reports about the actions of berberine on
NAT in lung cancer. Therefore, the present research is
designed is an attempt to study the effects of berberine
on activity and gene expression of NAT in human lung
cancer cell line A549 by means of the flow cytometry
and reverse transcription polymerase chain reaction
(RT-PCR), and to investigate whether berberine can re-
strain the activity of NAT to block the cancer-generat-
ing pathway so as to provide certain assistance for pre-
vention and treatment of cancer.
MATERIALS ANDMETHODS
Tumor cell line culture
The human lung cancer cell lines A-549 were provided
by the National Health Research Institute (NHRI) cell
bank (Taiwan, China). The A-549 cell lines were
placed in 75 cm2 culture flasks (Corning Inc., Corning,
NY, USA) and grown at 37℃ in humidified 5% CO2
and 95% air in F12K nutrient mixture supplemented
with 10% fetal bovine serum, penicillin-streptomycin
(10000 U/mL penicillin and 10 mg/mL streptomycin)
and 1% L-glutamine. Preparation of antibody essen-
tials: one BALB/cJ 6-week-old female mouse was sup-
plied by the Laboratory Animal Center of Medical Col-
lege of National Taiwan University (NTU), and the
mouse myeloma cells lines OKT 4 were provided by
NHRI cell bank (Taiwan, China).
Experimental drugs and main reagents
Berberine (product lot No. B-3251) was bought from
Sigma-Aldrich Inc. (St. Louis, MO, USA). F12K nutri-
ent mixture (product lot No. 21127022), Penicil-
lin-Streptomycin (product lot No. 15140122), L-gluta-
mine (product lot No. 25030081) and fetal bovine se-
rum (product lot No. 16000044) were bought from
Gibco BRL Co., Ltd. (Grand Island, NY, USA). Carni-
tine acetyltransferase (product lot No. C-4899) was
purchased from Sigma Chemical Co. (St. Louis, MO,
USA). RNeasy Mini Kit (product lot No. 74104) was
bought from QIAGEN GmbH (Hilden, Germany).
Pristine (product lot No. P-2870), Freund's Adjuvant
(complete) (product lot No. F-5881), Freund's Adju-
vant (incomplete) (product lot No. F-5506), phos-
phate buffered saline (PBS) (product lot No. P-5493),
trypsin (product lot No. T-8003), formaldehyde solu-
tion (product lot No. F-8775), Methanol (product lot
No. 34860), Triton X-100 (product lot No. T-8787),
sodium citrate (product lot No. W-302600), NAT sec-
ondary antibody (product lot No. M-7023), bovine se-
rum albumin (BSA) (product lot No. A-7906), sodium
azide (product lot No. S-2002), ethidium bromide
(product lot No. 46065), and propidium iodide (PI)
(product lot No. 287075) were produced by Sigma-Al-
drich Inc. (St. Louis, MO, USA).
Major apparatus
The following equipments were supplied as indicated:
RCO3000T-9-V Cell-CO2 Incubator (Thermo Scien-
tific Revco, Thermo Fisher Scientific Inc., Waltham,
MA, USA), LFI Horizontal Flow Workstation Floor &
Table Top (Laminar Flow Inc., Taipei, China), Hettich
EBA 12R Centrifuge (Andreas Hettich GmbH & Co.,
KG, Tuttlingen, Germany), Nikon Ellipse TE300 In-
verted Fluorescence Microscope (Nikon, Tokyo, Ja-
pan), FACSCalibur YoC 2009 Flow Cytometry System
(Becton Dickinson, San Jose, CA, USA), Gene Amp
PCR System 2400 Instrument (Perkin Elmer, Foster
City, CA, USA), Sub-Cell Model 96 Electrophoresis
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Chamber (Bio-Rad, CA, USA), ChemiDoc XRS+ Gel
Image Analysis System and Image Lab Software
(Bio-Rad, CA, USA).
Flow cytometric assay for cell viability of A549 cells
treated with or without Berberine
The A-549 cells were placed in 6-well plates at a densi-
ty of 1×106 cells/well and were grown for 24 h. Differ-
ent concentrations of berberine were then added to the
cells for a final concentration of 0.0008, 0.008, 0.08,
0.8 and 1.6 mM, while only adding double distilled
(D.D.) water for the controls and grown at 37℃ , 5%
CO2 and 95% air for 6, 12, 24 and 48 h. The viability
of A-549 cells was assayed by flow cytometry. Briefly,
about 1×106 cells/well were fixed gently (drop by drop)
by putting 70% ethanol (in PBS) in ice overnight and
were then resuspended in PBS containing 40 mg/mL
PI. After 30 min at 37℃ , the cells were analyzed on a
flow cytometry equipped with an argon ion laser at
488 nm wavelength. Then, the cell viability was deter-
mined.
NAT primary antibody preparation
The BALB/cJ mouse was used as the supplier of anti-
bodies, and was first injected with 0.5 mL of pristine
into the peritoneal cavity; 10-15 days later, 100 μg of
antigen (NAT), mixed intensively with an equal vol-
ume of Complete Freund's adjuvant through the emp-
ty needle linked with three-direction joints, was inocu-
lated to the back of mouse by subcutaneous injection
as the first immunization. Adjuvant was changed into
Incomplete Freund's adjuvant, and the operation was
repeated again after 10-15 days as the second immuni-
zation, then repeated once again after another 10-15
days as the third immunization. And myeloma cells
(0.5-1×106) in PBS were then injected into the mouse
by intraperitoneal injection after 10-15 days, and asci-
tes fluids of the mouse that normally generated after
one week was taken by suction and centrifugated for
5 min by 2000 rpm. The clear supernatant liquid was
collected as the polyclonal NAT primary antibodies for
further experiments.
Detecting the content of NAT in A549 cells
The A549 cells were inoculated into the culture dishes
and cultivated in 1×106 /well, with 2 mL F12K nutri-
ent mixture added. The first well added with 20 μL D.
D.Water was served as the control group. 20 μL of ber-
berine in 5 different concentrations (0.08, 0.8, 8, 80
and 160 mM) were respectively added into the second
to sixth well. And the cells were incubated for 24 h at
37℃ in 5% CO2 incubator. After the nutrient mixture
was removed and washed with PBS, a little Trypsin was
added to blow the cells by micropipette. The cells were
collected in 15 mL centrifuge tube and centrifugated at
4℃ for 5 min by 1500 rpm, and the clear supernatant
liquid was out welled. 5 mL of PBS was added and the
tubal wall was clapped to let the cells in suspension,
then centrifugated at 4℃ for 5 min by 1500 rpm.
100-200 μL PBS was reserved, and the cells were sus-
pended by the clapping tubal wall, then shifted into
96-well culture dish and centrifugated at 4℃ for 4 min
by 1500 rpm. 100 μL of 1% formaldehyde was added
after the clear supernatant liquid was removed; 5 min
later, 100 μL of 99% Methanol was added for 30 min
reaction and centrifugated at 4℃ for 4 min by 1500
rpm, and washed 3 times by 100 μL of PBS [including
0.1% bovine serum albumin (BSA)] after the clear su-
pernatant liquid was removed. 100 μL of 0.1% Triton
X-100 and 0.1% sodium citrate were added in PBS,
then reacted on ice for 45 min, centrifugated at 4℃ for
4 min by 1500 rpm, washed 3 times by 100 μL of PBS
(including 0.1% BSA) after the clear supernatant liq-
uid was removed. 100 μL of primary anti-mouse NAT
antibody (diluted 50 times by PBS including 0.1%
BSA and 0.1% sodium azide) was added and reacted
on ice for 2 h, and then centrifugated at 4℃ for 4 min
by 1500 rpm, and washed 3 times with the above-men-
tioned methods. 100 μL of 1% NAT secondary anti-
body (FITC-conjugated goat anti-mouse IgG antibody)
was added and reacted away from light for 30 min, and
then centrifugated at 4℃ for 4 min by 1500 rpm, and
washed 3 times with the above-mentioned methods.
100 μL of 0.1% BSA was added in PBS, then the con-
tent of NAT in the cells was analyzed by flow cytome-
try. This experiment was repeated 3 times.
Detecting the gene expression of NAT in A549 cells
by RT-PCR method
Like the procedures for detecting the content of NAT
in A549 cells, after adding a little Trypsin to blow the
cells by micropipette, the total RNA was drawn out by
the RNA Kit, and 500 ng of RNA was added into
the 0.5mL microcentrifuge tube, then added RNA
free water until the volume dose was 11.5 μL, added
1 μL of oligo-dT and reacted at 70℃ for 10 min,
added 7.5 μL of solution [2 μL of 100 mM dithioth-
reitol (DTT), 1 μL of 10 mM deoxy-ribonucleoside
triphosphate (dNTP), 4 μL of 5×buffer and 0.5 μL of
RT] and reacted at 37℃ for 1 h to obtain the comple-
mentary deoxyribonucleic acid (cDNA). 1 μL of cD-
NA was added into 24 μL of solution [19.05 μL of
H2O, 2.5μL of 10× buffer, 0.75μL ofMgCl2 , 0.5μL of
dNTP, 0.5 μL of NAT or β-actin primer 1 (Table 1),
0.5 μL of NAT or β-actin primer 2 (Table 1) and
0.2 μL of Taq DNA polymerase]. Polymerase chain re-
action (PCR) was performed under the following con-
ditions: preheating at 94℃ for 30 min, degeneration at
94℃ for 45 s, renaturation at 55℃ for 30 s, and elon-
gation at 72℃ for 90 s, for a total of 35 cycles; and
eventually reacted at 72℃ for 10 min, then preserved
the PCR end products at 4℃. DNA dye was added in-
to the sample in a ratio of 1∶5. The amplified products
of each sample were electrophoresed in 1.5% agarose
gel containing ethidium bromide dye. DNA marker
(DL2000) was used as the standard molecular weight.
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The gels with amplified fragments were observed and
photographed through a UV transilluminator. Gel elec-
trophoretic bands were imported into the ChemiDoc
XRS + Gel Image Analysis System. The β-actin was
used as an internal reference, the expression intensity
was analyzed by the ImageLab Software, and the results
were expressed as the absorbance ratio to the referenceβ-actin. For the upstream and downstream of the prim-
ers, see the following Table 1.11
Statistical analysis
The data are expressed as mean ± standard deviation
(SD). Statistical analysis of the data was performed us-
ing the IBM SPSS statistics 19.0 software (SPSS Inc.
Chicago, IL, USA). The LSD-t was used when the
comparisons were made among the groups. The re-
sults were considered to be statistically significant
when P<0.05.
RESULTS
Effect of berberine on the content of NAT in A549
cells
After the A549 cell lines were intervened by Berberine
and the intra-cellular NAT was dyed by antibody, it
was found by flow cytometry that the content of NAT
decreased with the increasing of drug concentration. In
the 24 h results, the percentage of NAT content in
A549 cells was 97.28%±0.93% in the control group;
after intervention by berberine with increasing concen-
tration of 0.0008, 0.008, 0.08, 0.8 and 1.6 mM, the
percentages were 98.71% ± 0.26% , 99.49% ± 0.18% ,
98.88%±0.25%, 68.04%±2.02%, 49.06%±0.84% re-
spectively. The contents of NAT in 0.0008 and
0.008 mM groups were higher than that in the control
group (P<0.05); but the contents of NAT in 0.8 mM
and 1.6 mM groups were lower than that in the con-
trol group (P<0.001).
Effect of berberine on gene expression of NAT in
A549 cells
After intervention by berberine in different concentra-
tions of 0.0008, 0.008, 0.08, 0.8 and 1.6 mM for 24 h,
the genes of NAT in A549 cell lines were amplified
through PCR with 35 cycles. It was found by Ultravio-
let (UV) that the mRNA expression of NAT decreased
with the increasing of berberine concentration. The de-
creased multiples of mRNA expression of NAT in A549
cell lines in 0.0008, 0.008, 0.08, 0.8 and 1.6 mM
groups were 0.99±0.01, 0.76±0.02, 0.74±0.03, 0.26±
0.05 and 0.10±0.04 respectively (Figure 3). Compared
with the control group, the mRNA expression levels of
NAT in 0.008, 0.08, 0.8 and 1.6 mM groups were sig-
nificantly lower (P<0.001). After the A549 cell lines
were intervened by the berberine in 0.8 mM concentra-
tion through time course observation with a 6 h inter-
val, the effect of action time of berberine on the cells
was that the mRNA expression of NAT decreased fol-
lowing the time-lapse. Action time of 0 h of berberine
on the cells was used as the control group. The de-
creased multiples of mRNA expression of NAT at the
6, 12, 18 and 24 h were 0.60±0.03, 0.63±0.03, 0.45±
0.05 and 0.19±0.04 respectively (Figure 2). The mRNA
expression levels of NAT in the 6, 12, 18 and 24 h
groups were quite obviously lower than that of the con-
trol group (all P<0.001).
Effect of berberine on A549 cells viability
After the A549 cells had been treated with or without
different concentrations of berberine for different
time-periods, the percentage of viable cells was deter-
mined by flow cytometry. The data showed that berber-
ine decreased the percentage of viable cells in a dose-
and time-dependent manner (Figure 3).
DISCUSSION
For the past few years, cancer has become the main
cause for death in human diseases. How to prevent and
treat cancer is a current important topic. Prevention
and treatment for cancer include two aspects: the one
is aiming at the tumor suppressor gene for controlling
the cancer cell growth and apoptosis; and the other one
is stressed on the cancer-generating pathway. The for-
mation of cancer can be divided into three stages: (a)
initiation phase: variation appears in genes of the cell
related to the extraneous material; (b) promotion
phase: present with cell phenotype changes; and (c)
progression phase: proliferation and pervasion of the
cancer cell, and with invasion to the other important
tissues and organs.12 The cancer-inducing factors main-
ly come from the environment, which includes: (a) cig-
Name of primer
β-actin
NAT
Upstream (primer 1)
Downstream (primer 2)
Upstream (primer 1)
Downstream (primer 2)
Sequence of primer
5'-GCTCGTCGTCGACAACGGCTC-3'
5'-CAAACATGATCTGGGTCATC TTCTC-3'
5'-CACCCGGATCCGGGATCATGGACATTGAAGC-3'
5'-GGTCCTCGAGTCAATCACCATGTTTGGGCAC-3'
Amplified product
fragment length (bp)
331
885
Notes: NAT: N-acetyltransferase; PCR: polymerase chain reaction. β-actin: genebank accession number NM-001101; NAT: genebank
accession number X17059.
Table 1 The PCR primers of β-actin and NAT
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arette: about 90% lung cancers are related with smok-
ing;13 (b) alcohol: it is related with the occurrence of he-
patic cirrhosis and liver cancer;14 (c) radiation: some ra-
dioactive substances can cause liver cancer or leukemia;15
(d) natural toxins: aflatoxin can induce live cancer;16 (e)
chemical materials: about 80% cancers are induced by
chemical carcinogens.17 The chemical carcinogens in-
cludes: (a) polycyclic aromatic hydrocarbons: this kind
of compounds commonly existing in natural environ-
ment, like coal, tobacco and barbecue, are assured of
the first inducing cause for cancer. Yamagiwa and Ichi-
kawa have confirmed that oncogens existing in oil of
cypress may induce skin cancer in rabbits; and the on-
cogen is banzo (α) pyrene, confirmed by Ernest Ken-
naway.18 (b) nitroso compounds: may be contained in
bloated pickles, if eating them for a long time, esopha-
geal cancer and gastric cancer may be induced.19 (c) or-
ganic compound and inorganic compound, including
acetamide, chloroform, dioxin, beryllium, cadmium,
arsenic etc, may cause cancer. (d) arylamines: they may
cause cancer through feeding,20 for example, 2-amino-
fluorene (2-AF) can be changed into 2-acetylaminoflu-
orene (2-AAF) after metabolism through NAT, later in-
to strong active ultimate carcinogens through other en-
zyme metabolism, and finally combined with DNA to
cause cancer.21 According to the speed of the arylamine
acetylated by NAT, the individuals can be distin-
guished as quick acetylator and slow acetylator.22 Epide-
miological data showed that the quick acetylator may
be easy to cause carcinoma of the colon and rectum,23
while the slow acetylator may be easy to induce blad-
der cancer.24 NAT, 34Kda in molecular weight, mainly
plays a role in metabolizing the external medicine or
compound for endogenic biochemistry synthesis or in-
ducing the activity; and it is also the first checkpoint to
metabolize chemical carcinogen. If there is no NAT,
strong active carcinogen may be formed. So, in compli-
ance with the theory of cancer-forming pathway, prog-
ress will be made if some kinds of medicines can inhib-
it the activity of NAT and block the pathway.
This study is aiming at the cancer cell forming path-
way. When chemical carcinogens like 2-AF get into the
body, the acetyl of acetylcoenzyme A (AcCoA) may be
transferred into the N-group of 2-AF by NAT in cyto-
plasm and form 2-AAF, then metabolized to N-hy-
droxy-acetylaminofluorene (N-OH-AAF) by Cyto-
chrome P-450, and combined further with DNA to
form the DNA adduct, thus causing the errors and mu-
tation when the cells are duplicating DNA, and induc-
ing cancer.2 The mutation of DNA adduct has a nar-
row spectrum25, so the process of cancer cell formation
through NAT pathway may be concluded as follows:
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Figure 1 Effect of different concentration of berberine on
gene expression of NAT in A549 cells
A: gel electrophoresis of RT-PCR products with primers for
NAT in different dose groups. 1: control group; 2: 0.0008 mM
group; 3: 0.008 mM group; 4: 0.08 mM group; 5: 0.8 mM
group; 6: 1.6 mM group. B: histograms of gel electrophoresis
of RT-PCR products with primers for NAT, and with corre-
sponding β-actin RT-PCR products as the controls in human
lung cancer cell line A549 after treatment with different con-
centrations of berberine for 24 h. Compared with the con-
trol group, aP<0.001. NAT: N-acetyltransferase; RT-PCR: re-
verse transcription polymerase chain reaction.
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Figure 2 Effect of action time of berberine on gene expres-
sion of NAT in A549 cells
A: gel electrophoresis of RT-PCR products with primers for
NAT in different time groups; B: histograms of gel electro-
phoresis of RT-PCR products with primers for NAT, and with
corresponding β-actin RT-PCR products in human lung can-
cer cell line A549 after treatment with 0.8 mM berberine for
time course. Compared with the control group, aP<0.001.
NAT: N-acetyltransferase; RT-PCR: reverse transcription poly-
merase chain reaction.
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2-AF↓ NAT
2-AAF↓ Cytochrome P-450
N-OH-AAF↓
N-Oac-AF↓
Nucleic acid adduct↓
DNA replication and mutation↓
Cancer cell
The main purpose of the present study is to determine
whether NAT activity in lung cancer cells can be re-
duced or not. We used NAT antibody to make dyeing
on A549 cancer cells intervened by berberine. The re-
sults showed that the intra-cellular NAT content pre-
sented a dose-dependent inhibited tendency following
the increasing of concentration of berberine, and the
mRNA expression of NAT also showed a similar ten-
dency. The NAT activity was restrained by berberine,
so we can draw an preliminary conclusion that berber-
ine may reduce the probability of forming cancer
caused by chemical materials acetylated to high affinity
adducts that speed DNA mutation when the cells are
exposed in environmental chemical materials. But after
all, A549 is the cell lines of cancerization; although ber-
berine can lower their NAT activity, how berberine
takes effect on NAT in human body is not yet sure.
And for this, further researches should be done to clari-
fy the prophylactic effect of berberine. The effect of via-
bility decreased at A549 cell line will be explored by us
in another ongoing study on cancer cell growth.
berberine is the major alkaloid extracted from the Chi-
nese herb Huanglian (Rhizoma Coptidis). The findings
about berberine from the present study can help us in
research on NAT activity of normal cells, and in study
of the pathway for cancer prevention and treatment.
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